Stock Movers: Intel, Zoetis, Datadog (Podcast)

Intel rallied on reports of a preliminary agreement with Apple to manufacture some device chips, potentially adding a major customer and U.S.-based production opportunity, though details remain unclear. Zoetis fell 22% after missing first-quarter sales expectations and cutting its 2026 forecast, citing weaker U.S. pet drug sales down 11% amid softer consumer spending and inflation. Datadog surged 31% to $188.73 after lifting full-year revenue guidance to $4.3B-$4.34B and adjusted EPS outlook to as much as $2.44, both above Wall Street estimates.

Analysis

The market is repricing three very different regimes at once: strategic re-shoring optionality, consumer demand fragility, and AI/software monetization durability. Intel’s move matters less as a single contract and more as a proof point that U.S.-based foundry capacity can become a geopolitical hedging asset for hyperscale customers; if that narrative sticks, the beneficiaries extend to the domestic semiconductor equipment stack and potentially to contract manufacturing names with U.S. capex exposure. The second-order risk is execution creep: even a preliminary relationship with a premium customer can compress margins near term if it forces customized lines, while also putting pressure on other foundry peers to defend share with pricing or capacity commitments.

Zoetis is the cleaner signal on consumer stress because pet care usually lags broader discretionary weakness; when premium animal-health spending rolls over, it suggests household balance-sheet pressure is now hitting “emotionally sticky” categories. That creates an air pocket for veterinary clinic traffic, pet retailers, and any ancillary premium spend exposed to repeat purchases, with the downside potentially persisting for several quarters rather than one print. The key question is whether this is a cyclical pause or the start of a valuation reset for defensive growth names that had been priced as quasi-noncyclical.

Datadog’s upgrade is more important for the software cohort than the stock itself: the market is signaling that infrastructure observability and security budgets are still being protected even as broader IT spend remains scrutinized. If revenue durability is being revised upward while margins expand, the read-through is bullish for best-in-class platform names and bearish for lower-quality, usage-sensitive software vendors that will struggle to keep up in an efficiency-focused buying environment. The contrarian risk is that the move has already forced a near-term reset in expectations, so the setup becomes less about chasing the stock and more about identifying laggards whose multiples have not yet adjusted to the higher bar.

Key Decisions for Investors

• Long INTC vs short a basket of Taiwan-centric foundry exposure over 1-3 months: trade the U.S. supply-chain premium while capping geopolitical headline risk; take profits if the stock re-rates beyond the point where execution is no longer discounted.
• Buy the first meaningful pullback in DDOG or structure a call spread into the next quarter: the guidance raise likely tightens peer multiples for 6-12 weeks, but chase risk is elevated after a large gap higher.
• Short ZTS on a 1-2 month horizon or buy puts/put spreads: the setup favors continued estimate cuts if consumer weakness propagates into repeat-purchase categories; cover on evidence of stabilization in U.S. pet spending.
• Pair long DDOG / short a lower-quality SaaS name with weaker guidance visibility: use the move to separate durable platform winners from usage-exposed software, targeting multiple divergence over the next earnings season.
• Watch AAPL on any confirmation of alternate U.S. chip sourcing: if the supply-chain diversification narrative gains traction, it supports a small strategic long in domestic semiconductor capex beneficiaries and keeps pressure on single-source foundry assumptions.